IBDEI2H1 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41909,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,41909,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,41910,0)
 ;;=G30.9^^159^2011^4
 ;;^UTILITY(U,$J,358.3,41910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41910,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,41910,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,41910,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,41911,0)
 ;;=G21.4^^159^2011^45
 ;;^UTILITY(U,$J,358.3,41911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41911,1,3,0)
 ;;=3^Vascular Parkinsonism
 ;;^UTILITY(U,$J,358.3,41911,1,4,0)
 ;;=4^G21.4
 ;;^UTILITY(U,$J,358.3,41911,2)
 ;;=^5003776
 ;;^UTILITY(U,$J,358.3,41912,0)
 ;;=G20.^^159^2011^34
 ;;^UTILITY(U,$J,358.3,41912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41912,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,41912,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,41912,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,41913,0)
 ;;=G25.0^^159^2011^15
 ;;^UTILITY(U,$J,358.3,41913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41913,1,3,0)
 ;;=3^Essential Tremor
 ;;^UTILITY(U,$J,358.3,41913,1,4,0)
 ;;=4^G25.0
 ;;^UTILITY(U,$J,358.3,41913,2)
 ;;=^5003791
 ;;^UTILITY(U,$J,358.3,41914,0)
 ;;=G25.2^^159^2011^44
 ;;^UTILITY(U,$J,358.3,41914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41914,1,3,0)
 ;;=3^Tremor,Other Spec Forms
 ;;^UTILITY(U,$J,358.3,41914,1,4,0)
 ;;=4^G25.2
 ;;^UTILITY(U,$J,358.3,41914,2)
 ;;=^5003793
 ;;^UTILITY(U,$J,358.3,41915,0)
 ;;=G25.1^^159^2011^43
 ;;^UTILITY(U,$J,358.3,41915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41915,1,3,0)
 ;;=3^Tremor,Drug-Induced
 ;;^UTILITY(U,$J,358.3,41915,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,41915,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,41916,0)
 ;;=G25.81^^159^2011^38
 ;;^UTILITY(U,$J,358.3,41916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41916,1,3,0)
 ;;=3^Restless Legs Syndrome
 ;;^UTILITY(U,$J,358.3,41916,1,4,0)
 ;;=4^G25.81
 ;;^UTILITY(U,$J,358.3,41916,2)
 ;;=^5003801
 ;;^UTILITY(U,$J,358.3,41917,0)
 ;;=G35.^^159^2011^31
 ;;^UTILITY(U,$J,358.3,41917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41917,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,41917,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,41917,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,41918,0)
 ;;=G40.901^^159^2011^13
 ;;^UTILITY(U,$J,358.3,41918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41918,1,3,0)
 ;;=3^Epilepsy,Not Intractable w/ Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,41918,1,4,0)
 ;;=4^G40.901
 ;;^UTILITY(U,$J,358.3,41918,2)
 ;;=^5003864
 ;;^UTILITY(U,$J,358.3,41919,0)
 ;;=G40.909^^159^2011^14
 ;;^UTILITY(U,$J,358.3,41919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41919,1,3,0)
 ;;=3^Epilepsy,Not Intractable w/o Status Epilepticus,Unspec
 ;;^UTILITY(U,$J,358.3,41919,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,41919,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,41920,0)
 ;;=G43.809^^159^2011^28
 ;;^UTILITY(U,$J,358.3,41920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41920,1,3,0)
 ;;=3^Migraine,Not Intractable w/o Status Migrainosus,Other
 ;;^UTILITY(U,$J,358.3,41920,1,4,0)
 ;;=4^G43.809
 ;;^UTILITY(U,$J,358.3,41920,2)
 ;;=^5003901
 ;;^UTILITY(U,$J,358.3,41921,0)
 ;;=G43.B0^^159^2011^30
 ;;^UTILITY(U,$J,358.3,41921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41921,1,3,0)
 ;;=3^Migraine,Ophthalmoplegic Not Intractable
 ;;^UTILITY(U,$J,358.3,41921,1,4,0)
 ;;=4^G43.B0
 ;;^UTILITY(U,$J,358.3,41921,2)
 ;;=^5003914
 ;;^UTILITY(U,$J,358.3,41922,0)
 ;;=G43.C0^^159^2011^17
 ;;^UTILITY(U,$J,358.3,41922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41922,1,3,0)
 ;;=3^Headache Syndromes,Periodic Not Intractable
